%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Marie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Christophe Beroud, Litaty Mbatchi, André van Kuilenburg, Christine Bobin-Dubigeon, Fabienne Thomas, Etienne Chatelut, Jean-Louis Merlin, Frédéric Pinguet, Christophe Ferrand, Judith Meijer, Alexandre Evrard, Laurence Llorca, Gilles Romieu, Philippe Follana, Thomas Bachelot, Loic Chaigneau, Xavier Pivot, Véronique Dieras, Rémy Largillier, Mireille Mousseau, Anthony Goncalves, Henri Roché, Jacques Bonneterre, Véronique Servent, Nadine Dohollou, Yann Château, Emmanuel Chamorey, Jean-Pierre Desvignes, David Salgado, Jean-Marc Ferrero, Gérard Milano
New advances in DPYD genotype and risk of severe toxicity under capecitabine
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 17 0 R/Annots 18 0 R/Contents 19 0 R/TrimBox[0 0 612 792]>>
endobj
18 0 obj
[20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R]
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref001)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref002)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref003)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref006)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref003)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref007)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref007)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref008)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref009)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref010)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref012)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref013)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref014)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref015)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref016)>>
endobj
35 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref006)>>
endobj
36 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref017)>>
endobj
37 0 obj
<>/Border[0 0 0]/Dest(Rpone.0175998.ref019)>>
endobj
38 0 obj
<>/Border[0 0 0]/A 39 0 R>>
endobj
39 0 obj
<>
endobj
19 0 obj
[40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R]
endobj
40 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 493.6144 m
199.9998 493.6144 l
199.9998 494.1145 l
575.9997 494.1145 l
f*
0.83 0.64 0.02 0 k
320.5417 354.8976 m
325.3039 354.8976 l
h
f*
327.515 354.8976 m
332.2772 354.8976 l
h
f*
232.9512 302.9102 m
237.7134 302.9102 l
h
f*
242.8724 302.9102 m
247.6346 302.9102 l
h
f*
359.0929 276.9449 m
363.8551 276.9449 l
h
f*
366.1228 276.9449 m
370.8283 276.9449 l
h
f*
318.3874 250.9228 m
323.1496 250.9228 l
h
f*
389.7071 237.9402 m
394.4693 237.9402 l
h
f*
500.5417 224.9008 m
505.3039 224.9008 l
h
f*
265.0961 211.9181 m
274.6205 211.9181 l
h
f*
279.7795 211.9181 m
289.3039 211.9181 l
h
f*
323.4331 185.8961 m
332.9575 185.8961 l
h
f*
258.0094 159.9307 m
267.5339 159.9307 l
h
f*
402.8598 120.926 m
412.3843 120.926 l
h
f*
414.652 120.926 m
424.1197 120.926 l
h
f*
497.2535 94.9039 m
502.0157 94.9039 l
h
f*
504.2835 94.9039 m
513.8079 94.9039 l
h
f*
518.9669 94.9039 m
528.4913 94.9039 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F6 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(silico)Tj
/F0 1 Tf
(\).)Tj
3.0136 0 Td
(Combined)Tj
4.7204 0 Td
(analysis)Tj
3.7895 0 Td
(of)Tj
1.0443 0 Td
(deleterious)Tj
5.0487 0 Td
(variants)Tj
/F5 1 Tf
3.676 0 Td
[()]TJ
/F0 1 Tf
(2A,)Tj
2.2618 0 Td
(I560S)Tj
2.8048 0 Td
(\()Tj
/F5 1 Tf
[()]TJ
/F0 1 Tf
(13\))Tj
2.5303 0 Td
(and)Tj
1.8619 0 Td
(D949V)Tj
3.2464 0 Td
(showed)Tj
3.6283 0 Td
(sig-)Tj
-37.626 -1.474 Td
(nificant)Tj
3.3478 0 Td
(association)Tj
5.1561 0 Td
(with)Tj
1.9812 0 Td
(grade)Tj
2.7451 0 Td
(34)Tj
1.862 0 Td
(toxicity)Tj
3.2464 0 Td
(\(sensitivity)Tj
4.8338 0 Td
(16.7%,)Tj
3.3001 0 Td
(positive)Tj
3.5686 0 Td
(predictive)Tj
4.4459 0 Td
(value)Tj
-34.487 -1.474 Td
(\(PPV\))Tj
2.8704 0 Td
(71.4%,)Tj
3.3001 0 Td
(relative)Tj
3.4016 0 Td
(risk)Tj
1.7545 0 Td
(\(RR\))Tj
2.3154 0 Td
(6.7,)Tj
1.8679 0 Td
(p)Tj
/F8 1 Tf
[( )]TJ
/F0 1 Tf
(0.001\))Tj
4.1535 0 Td
(but)Tj
1.5933 0 Td
(not)Tj
1.5934 0 Td
(with)Tj
1.9813 0 Td
(grade)Tj
2.7451 0 Td
(4)Tj
0.7638 0 Td
(toxicity.)Tj
3.521 0 Td
(Considering)Tj
5.4842 0 Td
(addi-)Tj
-37.3455 -1.474 Td
(tional)Tj
2.572 0 Td
(deleterious)Tj
5.0486 0 Td
(coding)Tj
3.1211 0 Td
(variants)Tj
3.6821 0 Td
(D342G,)Tj
3.6402 0 Td
(S492L,)Tj
3.3539 0 Td
(R592W)Tj
3.5268 0 Td
(and)Tj
1.8679 0 Td
(F100L)Tj
3.0256 0 Td
(increased)Tj
4.4996 0 Td
(the)Tj
1.5994 0 Td
(sensitiv-)Tj
-35.9372 -1.474 Td
(ity)Tj
1.2054 0 Td
(to)Tj
1.0503 0 Td
(26.7%)Tj
3.0256 0 Td
(for)Tj
1.3726 0 Td
(grade)Tj
2.7451 0 Td
(34)Tj
1.8679 0 Td
(toxicity)Tj
3.2404 0 Td
(\(PPV)Tj
2.5422 0 Td
(72.7%,)Tj
3.3061 0 Td
(RR)Tj
1.6471 0 Td
(7.6,)Tj
1.8738 0 Td
(p)Tj
/F8 1 Tf
[( )]TJ
/F0 1 Tf
(0.001\),)Tj
4.428 0 Td
(and)Tj
1.8679 0 Td
(was)Tj
1.9813 0 Td
(significantly)Tj
-32.1537 -1.474 Td
(associated)Tj
4.9471 0 Td
(with)Tj
1.9753 0 Td
(grade)Tj
2.7452 0 Td
(4)Tj
0.7638 0 Td
(toxicity)Tj
3.2464 0 Td
(\(sensitivity)Tj
4.8338 0 Td
(60%,)Tj
2.4766 0 Td
(PPV)Tj
2.208 0 Td
(27.3%,)Tj
3.3061 0 Td
(RR)Tj
1.653 0 Td
(31.4,)Tj
2.4169 0 Td
(p)Tj
0.7699 0 Td
(=)Tj
0.7996 0 Td
(0.001\),)Tj
3.3002 0 Td
(suggest-)Tj
-35.4419 -1.474 Td
(ing)Tj
1.5336 0 Td
(the)Tj
1.5934 0 Td
(clinical)Tj
3.1688 0 Td
(relevance)Tj
4.4996 0 Td
(of)Tj
1.0503 0 Td
(extended)Tj
4.2848 0 Td
(targeted)Tj
/F6 1 Tf
3.8492 0 Td
(DPYD)Tj
/F0 1 Tf
2.9778 0 Td
(genotyping.)Tj
5.3232 0 Td
(As)Tj
1.3845 0 Td
(compared)Tj
4.6189 0 Td
(to)Tj
1.0444 0 Td
(extended)Tj
-35.3285 -1.474 Td
(genotype,)Tj
4.5652 0 Td
(combining)Tj
4.7204 0 Td
(genotyping)Tj
5.0487 0 Td
(\(7)Tj
1.098 0 Td
(variants\))Tj
4.0103 0 Td
(and)Tj
1.8678 0 Td
(phenotyping)Tj
5.5977 0 Td
(\(U)Tj
/F8 1 Tf
[( !)]TJ
/F0 1 Tf
(16)Tj
2.9421 0 Td
(ng/ml\))Tj
2.9719 0 Td
(did)Tj
1.5277 0 Td
(not)Tj
1.5993 0 Td
(sub-)Tj
-35.9491 -1.474 Td
(stantially)Tj
4.058 0 Td
(increase)Tj
3.9505 0 Td
(the)Tj
1.5994 0 Td
(sensitivity,)Tj
4.7801 0 Td
(while)Tj
2.4586 0 Td
(impairing)Tj
4.2192 0 Td
(PPV)Tj
2.214 0 Td
(and)Tj
1.8619 0 Td
(RR.)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 566.1354 cm
BT
/F3 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusions)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 549.1275 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Exploring)Tj
4.3325 0 Td
(an)Tj
1.3188 0 Td
(extended)Tj
4.2848 0 Td
(set)Tj
1.5456 0 Td
(of)Tj
1.0444 0 Td
(deleterious)Tj
/F6 1 Tf
5.0426 0 Td
(DPYD)Tj
/F0 1 Tf
2.9839 0 Td
(variants)Tj
3.676 0 Td
(improves)Tj
4.2371 0 Td
(the)Tj
1.5933 0 Td
(performance)Tj
5.7767 0 Td
(of)Tj
/F6 1 Tf
-35.8357 -1.474 Td
(DPYD)Tj
/F0 1 Tf
2.9778 0 Td
(genotyping)Tj
5.0486 0 Td
(for)Tj
1.3786 0 Td
(predicting)Tj
4.4936 0 Td
(both)Tj
2.1424 0 Td
(grade)Tj
2.7451 0 Td
(34)Tj
1.8679 0 Td
(and)Tj
1.8679 0 Td
(grade)Tj
2.7451 0 Td
(4)Tj
0.7639 0 Td
(toxicities)Tj
4.0102 0 Td
(\(digestive)Tj
4.4459 0 Td
(and/or)Tj
3.0197 0 Td
(neu-)Tj
-37.5067 -1.474 Td
(rologic)Tj
3.121 0 Td
(and/or)Tj
3.0197 0 Td
(hematotoxic)Tj
5.341 0 Td
(ities\))Tj
2.2976 0 Td
(related)Tj
3.2404 0 Td
(to)Tj
1.0443 0 Td
(capecitabine,)Tj
6.0393 0 Td
(as)Tj
1.2652 0 Td
(compared)Tj
4.6189 0 Td
(to)Tj
1.0503 0 Td
(conventional)Tj
5.7588 0 Td
(geno-)Tj
-36.7965 -1.474 Td
(typing)Tj
2.8525 0 Td
(restricted)Tj
4.2907 0 Td
(to)Tj
1.0444 0 Td
(consensual)Tj
5.2157 0 Td
(variants)Tj
/F5 1 Tf
3.682 0 Td
[()]TJ
/F0 1 Tf
(2A,)Tj
/F5 1 Tf
2.2618 0 Td
[()]TJ
/F0 1 Tf
(13)Tj
1.8619 0 Td
(and)Tj
1.8679 0 Td
(D949V.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 450.9921 cm
BT
/F3 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 433.9842 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Since)Tj
2.3584 0 Td
(its)Tj
1.1451 0 Td
(launch)Tj
2.9254 0 Td
(in)Tj
1.0375 0 Td
(1998,)Tj
2.347 0 Td
(the)Tj
1.4684 0 Td
(5FU)Tj
1.9615 0 Td
(oral)Tj
1.7802 0 Td
(prodrug)Tj
3.5092 0 Td
(capecitabine)Tj
5.1817 0 Td
(has)Tj
1.5478 0 Td
(gradually)Tj
3.9231 0 Td
(become)Tj
3.3278 0 Td
(a)Tj
0.652 0 Td
(major)Tj
-33.1651 -1.2982 Td
(drug)Tj
2.1032 0 Td
(and)Tj
1.7178 0 Td
(is)Tj
0.8391 0 Td
(currently)Tj
3.8777 0 Td
(considered)Tj
4.5921 0 Td
(as)Tj
1.0035 0 Td
(a)Tj
0.6463 0 Td
(standard)Tj
3.7134 0 Td
(of)Tj
1.0034 0 Td
(care)Tj
1.8652 0 Td
(for)Tj
1.3776 0 Td
(advanced)Tj
3.9799 0 Td
(breast)Tj
2.6078 0 Td
(cancer.)Tj
3.0614 0 Td
(Capecitabine)Tj
-32.3884 -1.2983 Td
(is)Tj
0.8447 0 Td
(ultimately)Tj
4.2406 0 Td
(metabolized)Tj
5.0853 0 Td
(by)Tj
1.1792 0 Td
(thymidine)Tj
4.354 0 Td
(phosphorylase)Tj
5.9754 0 Td
(which)Tj
2.6532 0 Td
(produces)Tj
3.8778 0 Td
(5FU)Tj
1.9615 0 Td
(at)Tj
0.9525 0 Td
(target)Tj
2.5114 0 Td
(cell)Tj
1.5591 0 Td
(level.)Tj
-35.1947 -1.3039 Td
(Next,)Tj
2.3697 0 Td
(intracellularly-produced)Tj
9.9325 0 Td
(5FU)Tj
1.9616 0 Td
(enters)Tj
2.6475 0 Td
(either)Tj
2.5285 0 Td
(the)Tj
1.4684 0 Td
(anabolic)Tj
3.5886 0 Td
(or)Tj
1.0998 0 Td
(the)Tj
1.4684 0 Td
(catabolic)Tj
3.7587 0 Td
(route.)Tj
2.5738 0 Td
(Most)Tj
-33.3975 -1.2983 Td
(5FU)Tj
1.9558 0 Td
(is)Tj
0.8504 0 Td
(deactivated)Tj
4.7339 0 Td
(into)Tj
1.8368 0 Td
(fluorodihydrouraci)Tj
7.6592 0 Td
(l)Tj
0.4648 0 Td
(by)Tj
1.1792 0 Td
(ubiquitous)Tj
4.5184 0 Td
(dihydropyrimidine)Tj
7.869 0 Td
(dehydrogenase)Tj
-31.0675 -1.2982 Td
(\(DPD\),)Tj
3.1577 0 Td
(the)Tj
1.4684 0 Td
(rate-limiting)Tj
5.278 0 Td
(enzyme)Tj
3.2995 0 Td
(of)Tj
1.0148 0 Td
(5FU)Tj
1.9616 0 Td
(catabolism,)Tj
4.7452 0 Td
(expressed)Tj
4.0932 0 Td
(in)Tj
1.0318 0 Td
(various)Tj
3.1464 0 Td
(human)Tj
3.0784 0 Td
(tissues)Tj
2.8176 0 Td
(as)Tj
-35.0926 -1.3039 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(in)Tj
1.0375 0 Td
(human)Tj
3.0727 0 Td
(cancer)Tj
2.846 0 Td
(cells)Tj
1.9218 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
2.3017 0 Td
(Consequently,)Tj
5.9528 0 Td
(any)Tj
1.6611 0 Td
(DPD)Tj
2.2507 0 Td
(activity)Tj
3.118 0 Td
(variation)Tj
3.7984 0 Td
(within)Tj
2.8177 0 Td
(tumor)Tj
2.7439 0 Td
(or)Tj
-36.3569 -1.2983 Td
(normal)Tj
3.1464 0 Td
(cells)Tj
1.9219 0 Td
(may)Tj
1.9275 0 Td
(have)Tj
2.058 0 Td
(a)Tj
0.6519 0 Td
(major)Tj
2.6135 0 Td
(repercussion)Tj
5.3178 0 Td
(on)Tj
1.2756 0 Td
(availability)Tj
4.5297 0 Td
(of)Tj
1.0148 0 Td
(5FU)Tj
1.9616 0 Td
(for)Tj
1.3889 0 Td
(anabolism,)Tj
4.5695 0 Td
(and)Tj
1.7291 0 Td
(thus)Tj
-34.1062 -1.2983 Td
(may)Tj
1.9275 0 Td
(significantly)Tj
5.091 0 Td
(impact)Tj
2.9763 0 Td
(capecitabine)Tj
5.1874 0 Td
(pharmacodynamics)Tj
7.8746 0 Td
(.)Tj
0.4422 0 Td
(DPD)Tj
2.2507 0 Td
(deficiency)Tj
4.269 0 Td
(may)Tj
1.9275 0 Td
(be)Tj
1.1509 0 Td
(considered)Tj
-33.0971 -1.2982 Td
(as)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(major)Tj
2.6078 0 Td
(cause)Tj
2.3925 0 Td
(of)Tj
1.0148 0 Td
(capecitabine)Tj
5.1873 0 Td
(toxicity,)Tj
3.4243 0 Td
(and)Tj
1.7291 0 Td
(more)Tj
2.3414 0 Td
(generally)Tj
3.8324 0 Td
(fluoropyrimidine-re)Tj
8.0617 0 Td
(lated)Tj
2.1486 0 Td
(toxic-)Tj
-35.223 -1.304 Td
(ity)Tj
1.2415 0 Td
(risk)Tj
1.7121 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
2.5966 0 Td
(Accordingly,)Tj
5.3631 0 Td
(the)Tj
1.4683 0 Td
(wide)Tj
2.126 0 Td
(inter-patient)Tj
5.2667 0 Td
(variability)Tj
4.2179 0 Td
(of)Tj
1.0148 0 Td
(DPD)Tj
2.2507 0 Td
(enzyme)Tj
3.3052 0 Td
(activity)Tj
3.1181 0 Td
(measured)Tj
-33.681 -1.2982 Td
(in)Tj
1.0318 0 Td
(peripheral)Tj
4.3199 0 Td
(blood)Tj
2.5172 0 Td
(mononuclear)Tj
5.5785 0 Td
(cells)Tj
1.9162 0 Td
(\(PBMC\))Tj
3.5943 0 Td
(is)Tj
0.8504 0 Td
(significantly)Tj
5.091 0 Td
(correlated)Tj
4.2463 0 Td
(to)Tj
1.0261 0 Td
(systemic)Tj
3.6284 0 Td
(5FU)Tj
-33.8001 -1.2983 Td
(clearance)Tj
3.9458 0 Td
(in)Tj
1.0374 0 Td
(patients)Tj
3.3676 0 Td
(receiving)Tj
3.8664 0 Td
(i.v.)Tj
1.389 0 Td
(5FU)Tj
1.9615 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
2.3017 0 Td
(Of)Tj
1.2529 0 Td
(note,)Tj
2.2224 0 Td
(breast)Tj
2.6192 0 Td
(cancer)Tj
2.8403 0 Td
(treatment)Tj
4.1385 0 Td
(with)Tj
1.9956 0 Td
(capecita-)Tj
-32.9383 -1.3039 Td
(bine)Tj
1.9672 0 Td
(is)Tj
0.8447 0 Td
(particularly)Tj
4.8132 0 Td
(concerned)Tj
4.4163 0 Td
(since)Tj
2.2451 0 Td
(PBMC-DPD)Tj
5.2951 0 Td
(activity)Tj
3.118 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.126 0 Td
(shown)Tj
2.8459 0 Td
(to)Tj
1.0262 0 Td
(be)Tj
1.1508 0 Td
(lower)Tj
2.4491 0 Td
(in)Tj
-33.8397 -1.2983 Td
(women)Tj
3.2031 0 Td
(as)Tj
1.0148 0 Td
(compared)Tj
4.2406 0 Td
(to)Tj
1.0261 0 Td
(men)Tj
2.0126 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(],)Tj
1.5987 0 Td
(in)Tj
1.0375 0 Td
(line)Tj
1.7065 0 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.4684 0 Td
(observation)Tj
4.9039 0 Td
(that)Tj
1.7744 0 Td
(women)Tj
3.2032 0 Td
(are)Tj
1.4513 0 Td
(particularly)Tj
-30.6366 -1.2982 Td
(prone)Tj
2.5851 0 Td
(to)Tj
1.0262 0 Td
(suffer)Tj
2.4774 0 Td
(from)Tj
2.211 0 Td
(fluoropyrimidine)Tj
7.1263 0 Td
(toxicity)Tj
3.2031 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
1.5988 0 Td
(Importantly,)Tj
5.2837 0 Td
(cases)Tj
2.2223 0 Td
(of)Tj
1.0148 0 Td
(lethal)Tj
2.3981 0 Td
(toxicity)Tj
3.1975 0 Td
(have)Tj
-34.3443 -1.3039 Td
(been)Tj
2.1203 0 Td
(reported)Tj
3.6623 0 Td
(in)Tj
1.0318 0 Td
(patients)Tj
3.3732 0 Td
(with)Tj
1.9956 0 Td
(marked)Tj
3.2938 0 Td
(DPD)Tj
2.2507 0 Td
(deficiency)Tj
4.2633 0 Td
(after)Tj
2.0353 0 Td
(standard)Tj
3.7247 0 Td
(5FU)Tj
1.9615 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(])Tj
1.372 0 Td
(or)Tj
1.0998 0 Td
(capecitabine)Tj
-32.1843 -1.2983 Td
(administration)Tj
6.1681 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
-4.9719 -1.2983 Td
(DPD)Tj
2.2563 0 Td
(is)Tj
0.8447 0 Td
(encoded)Tj
3.6 0 Td
(by)Tj
/F13 1 Tf
1.1849 0 Td
[()13()25()]TJ
/F7 1 Tf
(,)Tj
2.982 0 Td
(a)Tj
0.6577 0 Td
(large)Tj
2.1599 0 Td
(gene)Tj
2.0807 0 Td
(spanning)Tj
3.9061 0 Td
(950)Tj
1.6497 0 Td
(kb)Tj
1.2246 0 Td
(on)Tj
1.2756 0 Td
(chromosome)Tj
5.4821 0 Td
(1p22)Tj
2.1657 0 Td
(\(23)Tj
1.5137 0 Td
(exons)Tj
-34.1799 -1.3039 Td
(comprising)Tj
4.7678 0 Td
(4399)Tj
2.1203 0 Td
(nucleotides\))Tj
5.1137 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.0806 0 Td
(DPD)Tj
2.2507 0 Td
(activity)Tj
3.1181 0 Td
(is)Tj
0.8447 0 Td
(controlled)Tj
4.32 0 Td
(at)Tj
0.9524 0 Td
(both)Tj
2.0579 0 Td
(transcriptional)Tj
6.1172 0 Td
(and)Tj
1.7291 0 Td
(post-)Tj
-35.4725 -1.2983 Td
(transcriptional)Tj
6.1114 0 Td
(levels.)Tj
2.6022 0 Td
(Post-transcriptional)Tj
8.1864 0 Td
(regulation)Tj
4.3086 0 Td
(of)Tj
1.0148 0 Td
(DPD)Tj
2.2564 0 Td
(involved)Tj
3.6453 0 Td
(microRNAs)Tj
5.0116 0 Td
(miR-27a)Tj
-33.1367 -1.2982 Td
(and)Tj
1.7234 0 Td
(miR-27b)Tj
3.736 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
2.075 0 Td
(At)Tj
1.1962 0 Td
(transcriptional)Tj
6.1115 0 Td
(level,)Tj
2.2393 0 Td
(more)Tj
2.3358 0 Td
(than)Tj
2.0239 0 Td
(200)Tj
1.6441 0 Td
(polymorphisms)Tj
6.4969 0 Td
(have)Tj
2.0523 0 Td
(been)Tj
2.1203 0 Td
(identified)Tj
-33.7547 -1.2983 Td
(in)Tj
/F13 1 Tf
1.0318 0 Td
[()13()25()]TJ
/F7 1 Tf
2.7609 0 Td
(coding)Tj
2.9593 0 Td
(regions.)Tj
/F13 1 Tf
3.3902 0 Td
[()39()]TJ
1.0772 0 Td
[()-13()14()7( )20(\n)]TJ
/F7 1 Tf
2.0466 0 Td
(studies)Tj
2.982 0 Td
(have)Tj
2.0636 0 Td
(demonstrated)Tj
5.76 0 Td
(that)Tj
1.7802 0 Td
(only)Tj
1.9729 0 Td
(a)Tj
0.6519 0 Td
(few)Tj
/F13 1 Tf
1.6158 0 Td
[()13()25()]TJ
/F7 1 Tf
2.7609 0 Td
(polymor-)Tj
-32.8533 -1.3039 Td
(phisms)Tj
3.067 0 Td
(have)Tj
2.0523 0 Td
(a)Tj
0.6463 0 Td
(significant)Tj
4.3823 0 Td
(deleterious)Tj
4.5921 0 Td
(impact)Tj
2.9764 0 Td
(on)Tj
1.2699 0 Td
(enzymatic)Tj
4.2916 0 Td
(activity,)Tj
3.3392 0 Td
(while)Tj
2.3641 0 Td
(even)Tj
2.0636 0 Td
(fewer)Tj
2.4038 0 Td
(are)Tj
1.4399 0 Td
(associ-)Tj
-34.8885 -1.2983 Td
(ated)Tj
1.9048 0 Td
(with)Tj
1.9956 0 Td
(proficient)Tj
4.1329 0 Td
(\(i.e.)Tj
1.7008 0 Td
(elevated\))Tj
3.7927 0 Td
(enzyme)Tj
3.2995 0 Td
(activity)Tj
3.1181 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
3.2541 0 Td
(It)Tj
0.8561 0 Td
(has)Tj
1.5477 0 Td
(been)Tj
2.1203 0 Td
(clearly)Tj
2.8176 0 Td
(demonstrated)Tj
-30.5402 -1.2982 Td
(that)Tj
/F13 1 Tf
1.7744 0 Td
[()13()25()]TJ
/F7 1 Tf
2.761 0 Td
(deleterious)Tj
4.5977 0 Td
(variants)Tj
ET
Q
q
1 j
1 J
0 w
6.9998 0 0 6.9998 325.2472 112.6488 cm
BT
/F14 1 Tf
1 TL
0 0 Td
()Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 329.2157 109.0204 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(2A)Tj
1.3832 0 Td
(\(c.1905+1G)Tj
/F15 1 Tf
0 Tc
(>)Tj
/F7 1 Tf
-0.004 Tc
(A\),)Tj
6.8995 0 Td
(D949V)Tj
3.0784 0 Td
(\(c.2846A)Tj
/F15 1 Tf
0 Tc
(>)Tj
/F7 1 Tf
-0.004 Tc
(T\),)Tj
5.743 0 Td
(and)Tj
ET
Q
q
1 j
1 J
0 w
6.9998 0 0 6.9998 517.6062 112.6488 cm
BT
/F14 1 Tf
1 TL
0 0 Td
()Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 521.5748 109.0204 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(13)Tj
1.1735 0 Td
(\(I560S,)Tj
-33.3295 -1.3039 Td
(c.1679T)Tj
/F15 1 Tf
0 Tc
(>)Tj
/F7 1 Tf
-0.004 Tc
(G\))Tj
5.2101 0 Td
(are)Tj
1.4456 0 Td
(relevant)Tj
3.4243 0 Td
(predictors)Tj
4.2859 0 Td
(of)Tj
1.0148 0 Td
(fluoropyrimidine-related)Tj
10.2047 0 Td
(toxicities)Tj
3.7984 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
4.2462 0 Td
(From)Tj
2.4491 0 Td
(a)Tj
-36.0791 -1.2982 Td
(prospective)Tj
4.7849 0 Td
(trial)Tj
1.8368 0 Td
(conducted)Tj
4.4277 0 Td
(on)Tj
1.2756 0 Td
(2594)Tj
2.1203 0 Td
(colon)Tj
2.4548 0 Td
(cancer)Tj
2.8403 0 Td
(patients)Tj
3.3675 0 Td
(receiving)Tj
3.8665 0 Td
(adjuvant)Tj
3.702 0 Td
(5FU-based)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 441.0141 745.7952 cm
BT
/F6 1 Tf
1 TL
-0.005 Tc
0 0 Td
(DPYD)Tj
/F0 1 Tf
2.9622 0 Td
(and)Tj
1.8567 0 Td
(capecitab)Tj
4.1953 0 Td
(ine-related)Tj
4.8544 0 Td
(toxicity)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01759)Tj
4.089 0 Td
(98)Tj
0 g
2.0906 0 Td
(May)Tj
2.0906 0 Td
(8,)Tj
1.0346 0 Td
(2017)Tj
35.7806 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(19)Tj
/F9 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F10 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3748 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interest)Tj
ET
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
BT
9.9213 82.7156 Td
(exist.)Tj
ET
Q
endstream
endobj
57 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 17 0 R/Annots 61 0 R/Contents 62 0 R/TrimBox[0 0 612 792]>>
endobj
60 0 obj
<>
endobj
63 0 obj
<>
endobj
66 0 obj
<>stream
MinionPro-Regular 6 )
H? HD H\ ' - 3 > H N T Z ` j q t { +2=CIU[cnz~
"(.9CIOU[elov|&-8>DPV^iuy &+/49@DGLPU[]_ahjmru|
&-4;BIPW^elsz
")07>ELSZahov} %,3:AHOV]dkry#/;JTey ! ( / 6 = D K R Y ` g n u |
$
+
2
9
@
G
N
U
\
c
j
q
x
'.5<CJQX_fmt{ #*18?FMT[bkry
"
)
0
7
>
E
J
O
W
d
q
v
$+29@GNU\cjqx '.5<CJQX_fmt{ #*18?FMT[bipw~
&-4;BIPW^elsz !(/6=DOVcpuz-B\v$<Tdy*5@Tanz!2>O_fmt{ $-6?HQZclu~ )2;DMV^gpy $-6?HQZclu~ )2;DM\enwcommaaccentAbreveAmacronAogonekAEacuteCacuteCcaronCcircumflexCdotaccentDcaronDcroatEbreveEcaronEdotaccentEmacronEngEogonekGbreveGcircumflexGcommaaccentGdotaccentHbarHcircumflexIbreveIJImacronIogonekItildeJcircumflexKcommaaccentLacuteLcaronLcommaaccentLdotNacuteNcaronNcommaaccentObreveOhungarumlautOmacronOslashacuteRacuteRcaronRcommaaccentSacuteScedillaScircumflexScommaaccentTbarTcaronTcommaaccentUbreveUhungarumlautUmacronUogonekUringUtildeWacuteWcircumflexWdieresisWgraveYcircumflexYgraveZacuteZdotaccentIdotaccentabreveamacronaogonekaeacutecacuteccaronccircumflexcdotaccentdcarondcroatebreveecaronedotaccentemacronengeogonekgbrevegcircumflexgcommaaccentgdotaccenthbarhcircumflexibreveijimacroniogonekitildejcircumflexkcommaaccentlacutelcaronlcommaaccentldotnacutencaronncommaaccentobreveohungarumlautomacronoslashacuteracutercaronrcommaaccentsacutescedillascircumflexscommaaccenttbartcarontcommaaccentubreveuhungarumlautumacronuogonekuringutildewacutewcircumflexwdieresiswgraveycircumflexygravezacutezdotaccentkgreenlandiclongsnapostrophetonosdieresistonosAlphaBetaGammaDeltaEpsilonZetaEtaThetaIotaKappaLambdaMuNuXiOmicronPiRhoSigmaTauUpsilonPhiChiPsiOmegaAlphatonosEpsilontonosEtatonosIotatonosIotadieresisOmicrontonosUpsilontonosUpsilondieresisOmegatonosuni1FBBuni1F09uni1F0Duni1F0Buni1F0Funi1FB8uni1FBAuni1FBCuni1F89uni1F8Duni1F8Buni1F8Funi1F88uni1F8Cuni1F8Auni1F8Euni1F08uni1F0Cuni1F0Auni1F0Euni1FB9uni1FC9uni1F19uni1F1Duni1F1Buni1FC8uni1F18uni1F1Cuni1F1Auni1FCBuni1F29uni1F2Duni1F2Buni1F2Funi1FCAuni1FCCuni1F99uni1F9Duni1F9Buni1F9Funi1F98uni1F9Cuni1F9Auni1F9Euni1F28uni1F2Cuni1F2Auni1F2Euni1FDBuni1F39uni1F3Duni1F3Buni1F3Funi1FD8uni1FDAuni1F38uni1F3Cuni1F3Auni1F3Euni1FD9uni1FFBuni1F69uni1F6Duni1F6Buni1F6Funi1FFAuni1FFCuni1FA9uni1FADuni1FABuni1FAFuni1FA8uni1FACuni1FAAuni1FAEuni1F68uni1F6Cuni1F6Auni1F6Euni1FF9uni1F49uni1F4Duni1F4Buni1FF8uni1F48uni1F4Cuni1F4Auni1FECuni1FEBuni1F59uni1F5Duni1F5Buni1F5Funi1FE8uni1FEAuni1FE9alphabetagammadeltaepsilonzetaetathetaiotakappalambdanuxiomicronpirhosigmatauupsilonphichipsiomegaalphatonosepsilontonosetatonosiotatonosiotadieresisomicrontonosupsilontonosupsilondieresisomegatonosiotadieresistonosupsilondieresistonosuni03C2uni0374uni0375uni037Euni03D0uni03DAuni03DEuni03E0uni03F0uni1FBDuni1FBEuni1FC1uni1FCDuni1FCEuni1FCFuni1FDDuni1FDEuni1FDFuni1FEDuni1FEEuni1FFEuni1F00uni1F01uni1F02uni1F03uni1F04uni1F05uni1F06uni1F07uni1F10uni1F11uni1F12uni1F13uni1F14uni1F15uni1F20uni1F21uni1F22uni1F23uni1F24uni1F25uni1F26uni1F27uni1F30uni1F31uni1F32uni1F33uni1F34uni1F35uni1F36uni1F37uni1F40uni1F41uni1F42uni1F43uni1F44uni1F45uni1F50uni1F51uni1F52uni1F53uni1F54uni1F55uni1F56uni1F57uni1F60uni1F61uni1F62uni1F63uni1F64uni1F65uni1F66uni1F67uni1F70uni1F71uni1F72uni1F73uni1F74uni1F75uni1F76uni1F77uni1F78uni1F79uni1F7Auni1F7Buni1F7Cuni1F7Duni1F80uni1F81uni1F82uni1F83uni1F84uni1F85uni1F86uni1F87uni1F90uni1F91uni1F92uni1F93uni1F94uni1F95uni1F96uni1F97uni1FA0uni1FA1uni1FA2uni1FA3uni1FA4uni1FA5uni1FA6uni1FA7uni1FB0uni1FB1uni1FB2uni1FB3uni1FB6uni1FB7uni1FC2uni1FC3uni1FC4uni1FC6uni1FC7uni1FD0uni1FD1uni1FD2uni1FD3uni1FD6uni1FD7uni1FE0uni1FE1uni1FE2uni1FE3uni1FE4uni1FE5uni1FE6uni1FF2uni1FF3uni1FF4uni1FF6uni1FF7uni1FB4uni1FE7uniEFD5anoteleiauni03D1uni03D5uni03D6franclirapesetaEuroafii61289estimatedpartialdiffproductsummationuni2219radicalinfinityintegralapproxequalnotequallessequalgreaterequallozengeuni02C9uniEFEDuniEFEEuniEFF1uniEFF2uniEFF3uniEFF5uniEFF7AcuteCaronDieresisDieresisAcuteDieresisGraveGraveHungarumlautMacroncyrBrevecyrFlexdblGravecyrbrevecyrflexdblgravedieresisacutedieresisgraveuniF635uniF637uniF638uniF639uniF6DCuniF63AuniF63BuniF63CuniF63DuniF63EuniF63FuniF640uniF641uniF642uniF628uniF643uniF644uniF645uniF646uniF647uniF648uniF649uniF64AuniF64BuniF64CuniF64DuniF64EuniF64FuniF650uniF651uniF652uniF653uniF654uniF655uniF656uniF657uniF658uniF659uniF65AuniF65BuniF65CuniF65DuniF65EuniF65FuniF660uniF629uniF62AuniF62BuniF62CuniF62DuniF661uniF662uniF663uniF664uniF665uniF666uniF667uniF668uniF669uniF66AuniF66BuniF66CuniF62EuniF62FuniF630uniF631uniF632uniF66DuniF66EuniF66FuniF670uniF671uniF672uniF673uniF674uniF675uniF676uniF677uniF678uniF679uniF67AuniF67BuniF67CuniF67DuniF67EuniF67FuniF680uniF681uniF682uniF683uniF684uniF685uniF686uniF687uniF688uniF689uniF68AuniF68BuniF68CuniF68DuniF68EuniF68FuniF690uniF691uniF692uniF693uniF694uniF695uniF696uniF697uniF698uniF699uniF69AuniF69BuniF69CuniF69DuniF69EuniF69FuniF6A0uniF6A1uniF6A2uniF6A3uniF6A4uniF6A5uniF6A6uniF6A7uniF6A8uniF6A9uniF6AAuniF6ABuniF6ACuniF6ADuniF6AEuniF6AFuniF6B0uniF6B1uniF6B2uniF6B3uniF6B4uniF6B5uniF6B6uniF6B7uniF6B8uniF6B9uniF6BAuniF6BBuniF6BCuniF6BDuniF633c_hc_kc_tf_bf_f_bf_f_hf_f_kf_f_tf_hf_jf_f_jf_kf_ts_puniFB06T_hlongs_blongs_hlongs_ilongs_klongs_llongs_longsuniFB05longs_longs_ilongs_longs_la.ende.endm.endn.endr.endK.altR.altk.altcaron.altcommaaccent.altpeseta.altAlphaiotasub.altAlphaiotasubasper.altAlphaiotasubasperacute.altAlphaiotasubaspergrave.altAlphaiotasubaspertilde.altAlphaiotasublenis.altAlphaiotasublenisacute.altAlphaiotasublenisgrave.altAlphaiotasublenistilde.altEtaiotasub.altEtaiotasubasper.altEtaiotasubasperacute.altEtaiotasubaspergrave.altEtaiotasubaspertilde.altEtaiotasublenis.altEtaiotasublenisacute.altEtaiotasublenisgrave.altEtaiotasublenistilde.altOmegaiotasub.altOmegaiotasubasper.altOmegaiotasubasperacute.altOmegaiotasubaspergrave.altOmegaiotasubaspertilde.altOmegaiotasublenis.altOmegaiotasublenisacute.altOmegaiotasublenisgrave.altOmegaiotasublenistilde.altEuro.fittedcent.fittedcolonmonetary.fitteddollar.fittedflorin.fittedfranc.fittedlira.fittednumbersign.fittedsterling.fittedyen.fittedEuro.oldstylecolonmonetary.oldstyleestimated.oldstyleflorin.oldstylefranc.oldstylelira.oldstylenumbersign.oldstylesterling.oldstyleyen.oldstylefranc.taboldstylelira.taboldstyleorn.001orn.002orn.003orn.004orn.005orn.006orn.007orn.008orn.009orn.010orn.011orn.012orn.013orn.014orn.015orn.016orn.017orn.018orn.019orn.020orn.021orn.022orn.023afii10023afii10031afii10022afii10049T_h.caronafii10070afii10196afii10026afii10021afii10846afii10193afii10107afii10024afii10195afii10041afii10037afii10109afii10053afii10045afii10108afii10040afii10104afii10036afii10078afii10074afii10060afii10046afii10052afii10087afii10050afii10145afii10057afii10059afii10146afii10088afii10101afii10054afii10058Rholenisafii10025afii10099afii10068afii10035afii10048afii10089afii10105afii10085afii10020afii10077afii10106afii10019afii10076afii10110afii10100afii10090afii10028afii10095afii10147afii10066afii10098afii10082afii10061afii10103afii10102afii10083afii10027afii10072afii10039afii61352afii10069afii10094afii10038afii10034afii10148afii10032afii10194afii10033afii10075afii10017afii10081afii10056afii10084afii10044afii10030afii10051afii10047afii10018afii10080afii10042afii10071afii10029afii10062afii10065afii10097T_h.commaaccentafii10096afii10079afii10091afii10093afii10064afii10043afii10092uni2215uni021Bafii10073afii10067uni00A0uni021Aafii10086afii10055uni0394uni03BCuni03A9uni00ADCopyright 2000 Adobe Systems Incorporated. All Rights Reserved. U.S. Patent Des. 337,604.Minion is either a registered trademark or a trademark of Adobe Systems Incorporated in the United States and/or other countries.Minion Pro RegularMinion Pro% i WZ5:`v22> % I
/
2
I
o
#3p~U
D
e
!o#]emE %<Jeov~EMfjtFp|,S-AZ0=DK +^&7NQy(/S_dl 5Rk$=Valsz"'-@T_gos{ ) . > N ^ d n v ~ !!!!'!3!?!H!Q!Z!]!c!i!n!s!x!!!!!!!!!!!!!"""#"'"3"?"K"W"c"k"s"{""""""""""""""c&oEr^7 JB@H *W2c~sp&m!1= 4:$kYyywRvzwrZnon?˘iNUddLoLݪ
~}}vywS6vO(Zp^TrǕ؍8x`?NYwUVYWE}zyMhummR~Kfowx}|txcBzuyBpOwTxql[LPҩy}~Bxxhzqlc#T0@9
5/j,X^M8Uruuoquvqiff{bE<H8XUo^bb_rMG'Н=[W}yQSSۚ$P|TzTyT'
ajqyzx||rrpwttozpj`lWHrʥaiqyo
|rqpxt@tpyqjalVHr]yt/m'mDx]pIsn8AgmxpQAz4wv~s}~vstzf|oęgfeoszvwzxu$wny|YgJO-ʆea]>9+ZhchAB_\?#^|m[5v-<<[FL LHHq˂~XxAo4uFabfqaf%f+rrs}ǔcqW "* ڟŇՊvx|po~}wUJN<0o-כtzr[ {"!coч~^o]/6'orsBp0ZlZqRoGt{_Fpq|iiMkTratap`DabuvCICpAϦ{~{lpˇBDDpӐ qoكtYoNU)gI_Z`yӔodžF/INlw71oC
ŸԱȗГnoՆ3$811xrdcQD:0] ;hJjp~djmplXhZfYxnmmyf^#MR:AgszvT]jjZ?_ynZQ{sNHyZdƨ]O틯֯}ޣDyZ{kvumofFMk_VYЄ#ms^@L A_!Z Z|蒯}~rqyg|usqrwgmazԬqbfZBoل5|%69o<3oZMZJuׇ3c T{ddmvrjY_VpŇkrkGpφ}8Fgsmy]pWSy/OBR7WXjfeolw}v84o~}xUGP~72pC
~㿊IK
NϪb98IPq
`y[~XsłI\FL
ދ.R۲vhl_@oۅ8(85oq͗ƫ>(3XOG7]_\i^%"Ba:Jy.}eu}|wzq]is|~ґϐuCDDEp
ؑ~P|xhcMp^},
qkuGuzwv~s}~ust}e{nęgfR5BcH
蠓`
i
`c
v
y
蠚}xsnyvrpyh&T~Y|S|Q4xrqxvrpyhrqVVrm